{"id":"https://openalex.org/W2007011615","doi":"https://doi.org/10.1097/00008877-199512000-00010","title":"DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors","display_name":"DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors","alternate_titles":[],"publication_year":1995,"publication_date":"1995-12-01","ids":{"openalex":"https://openalex.org/W2007011615","doi":"https://doi.org/10.1097/00008877-199512000-00010","mag":"2007011615","pmid":"https://pubmed.ncbi.nlm.nih.gov/11224388"},"language":"en","primary_location":{"id":"doi:10.1097/00008877-199512000-00010","doi":"https://doi.org/10.1097/00008877-199512000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-199512000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007011615"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087049093","display_name":"T. E. Sipes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. E. Sipes","raw_affiliation_strings":["Departments of Neuroscience and Psychiatry, University of California at San Diego, La Jolla, CA 92093\u20130804, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience and Psychiatry, University of California at San Diego, La Jolla, CA 92093\u20130804, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034576114","display_name":"Mark A. Geyer","orcid":"https://orcid.org/0000-0001-6137-9331","observed_orcids":["https://orcid.org/0000-0001-6137-9331"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. A. Geyer","raw_affiliation_strings":["Departments of Neuroscience and Psychiatry, University of California at San Diego, La Jolla, CA 92093\u20130804, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neuroscience and Psychiatry, University of California at San Diego, La Jolla, CA 92093\u20130804, USA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":null,"apc_paid":null,"fwci":3.9684,"has_fulltext":false,"cited_by_count":129,"citation_normalized_percentile":{"value":0.93628912,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"6","issue":"8","first_page":"839???842","last_page":"839???842"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8246999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8246999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.16979999840259552,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.9549999833106995},{"id":"https://openalex.org/keywords/startle-response","display_name":"startle response","score":0.9309999942779541},{"id":"https://openalex.org/keywords/digital-object-identifiers","display_name":"digital object identifiers","score":0.6190000176429749},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.8880000114440918},{"id":"https://openalex.org/keywords/5-ht2c-receptor","display_name":"5-HT2C receptor","score":1.0},{"id":"https://openalex.org/keywords/sensorimotor-gating","display_name":"sensorimotor gating","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mdl-100-907","display_name":"MDL 100,907","score":0.9240000247955322},{"id":"https://openalex.org/keywords/serotonin-receptor-antagonists","display_name":"serotonin antagonists","score":0.6800000071525574},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.5040000081062317},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.968999981880188},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.9887713193893433},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.8897900581359863},{"id":"https://openalex.org/C194544171","wikidata":"https://www.wikidata.org/wiki/Q21105679","display_name":"Gating","level":2,"score":0.6961650848388672},{"id":"https://openalex.org/C2777845764","wikidata":"https://www.wikidata.org/wiki/Q430986","display_name":"Startle response","level":2,"score":0.610364556312561},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6058636903762817},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.569117546081543},{"id":"https://openalex.org/C2779705967","wikidata":"https://www.wikidata.org/wiki/Q2271368","display_name":"Sensory gating","level":3,"score":0.5661311745643616},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5479356050491333},{"id":"https://openalex.org/C126855140","wikidata":"https://www.wikidata.org/wiki/Q14891424","display_name":"5-HT2A receptor","level":5,"score":0.5446968674659729},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5386836528778076},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5247635841369629},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5020797252655029},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.41610485315322876},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3916265666484833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3444180488586426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31444019079208374},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09839245676994324}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/00008877-199512000-00010","doi":"https://doi.org/10.1097/00008877-199512000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-199512000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},{"id":"pmid:11224388","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224388","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1986772828","https://openalex.org/W1972895831","https://openalex.org/W2067357451","https://openalex.org/W2090855318","https://openalex.org/W2039652186","https://openalex.org/W1967229911","https://openalex.org/W2005756201","https://openalex.org/W4365458741","https://openalex.org/W2112891613","https://openalex.org/W2071946383"],"abstract_inverted_index":{"Prepulse":[0],"inhibition":[1],"(PPI)":[2],"of":[3,12,49,65,75,111,134,146,169,173,179],"the":[4,50,60,63,66,72,83,96,109,123,126,132,153,157,170,180,185],"startle":[5],"response":[6],"is":[7,129],"used":[8,142],"as":[9,47,143],"a":[10,144,164,177],"measure":[11],"sensorimotor":[13,135,147,186],"inhibitory":[14],"processes.":[15],"Deficits":[16],"in":[17,22,38,131,139,151,184,189],"PPI":[18,33,76,112,140,174],"have":[19],"been":[20],"found":[21,150],"patients":[23],"with":[24],"schizophrenia,":[25,152],"obsessive":[26],"compulsive":[27],"disorder":[28],"(OCD)":[29],"and":[30,57,91,105,191],"Huntington's":[31],"disease.":[32],"can":[34],"also":[35],"be":[36,163],"disrupted":[37],"animals":[39],"through":[40],"manipulations":[41],"that":[42,70,82,125,159],"augment":[43],"serotonergic":[44,171,182],"activity,":[45],"such":[46],"administration":[48],"serotonin":[51],"(5-HT)":[52],"agonists":[53],"8-OH-DPAT,":[54],"RU":[55],"24969":[56],"DOI.":[58],"In":[59],"present":[61,154],"experiment":[62],"identity":[64],"5-HT":[67],"receptor":[68,128],"subtype":[69],"mediates":[71],"DOI-induced":[73],"disruption":[74],"was":[77],"examined.":[78],"Dose-response":[79],"studies":[80],"revealed":[81],"novel":[84,165],"5-HT(2A)":[85,127],"antagonist,":[86],"MDL":[87,160],"100,907":[88,161],"(0.01,":[89],"0.1":[90],"1.0mg/kg,":[92],"s.c.),":[93,107],"but":[94],"not":[95],"new":[97],"5-HT(2C)":[98],"antagonist":[99],"SDZ":[100],"SER":[101],"082":[102],"(0.125,":[103],"0.25":[104],"0.5mg/kg,":[106,118],"prevented":[108],"loss":[110],"induced":[113],"by":[114],"DOI":[115],"(0.25":[116],"or":[117],"s.c.).":[119],"The":[120],"results":[121],"support":[122],"hypothesis":[124],"involved":[130],"modulation":[133],"gating.":[136],"Because":[137],"deficits":[138],"are":[141],"model":[145,178],"gating":[148,187],"abnormalities":[149,188],"study":[155],"supports":[156],"view":[158],"may":[162,175],"atypical":[166],"antipsychotic.":[167],"Studies":[168],"substrates":[172],"provide":[176],"possible":[181],"role":[183],"schizophrenia":[190],"OCD":[192],"patients.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007011615","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
